retatrutide type 2 diabetes trial 2024 Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Triple hormone receptor agonist retatrutide

However, its essential to undergo Sermorelin therapy under the supervision of a medical professional to ensure proper dosing and to monitor for potential side effects, ensuring the safest and most effective outcomes

"For retatrutide, the findings from TRIUMPH-4 are encouraging, and with seven additional phase 3 readouts expected in 2026, we believe retatrutide could become an important option for patients with significant weight loss needs and certain complications, including knee osteoarthritis," a Lilly spokesperson said in a statement to Fox News Digital

I wanted a clinic that was streamlined and didn't waste my time, and they delivered

What does Orderly Meds prescribe

This trial aims to investigate whether retatrutide may positively impact cardiovascular health and reduce the risk of events [29]

Read here for more information on the class of drugs known as GLP-1 agonists